Fosfomycin disodium

DRUG3 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Conditions

Asymptomatic BacteriuriaBacterial InfectionMultiple-drug ResistancePathogen ResistancePseudomonas InfectionUrinary Tract Infection

Phase 1

Safety, Tolerability and PK 3-Period Crossover Study Comparing 2 Single Doses of ZTI-01 and Monurol® in Healthy Subjects

CompletedNCT02178254

National Institute of Allergy and Infectious Diseases (NIAID)Pseudomonas Infection

Start: 2014-08-31End: 2014-10-31Updated: 2016-04-04

Intravenous Fosfomycin Pharmacokinetics Study

CompletedNCT03910673

National Institute of Allergy and Infectious Diseases (NIAID)Bacterial Infection, Multiple-drug Resistance, Pathogen Resistance

Start: 2019-06-27End: 2020-12-17Updated: 2023-10-23

Phase 4

Perioperative Fosfomycin in the Prophylaxis of Urinary Tract Infection in Kidney Transplant Recipients

CompletedNCT03235947

Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranAsymptomatic Bacteriuria, Urinary Tract Infection

Start: 2016-09-07End: 2017-11-06Updated: 2017-11-13

Related Papers

Evaluation of the safety profile and intrapulmonary pharmacokinetics of intravenous fosfomycin in healthy adults

Antimicrobial Agents and Chemotherapy2025-01-081 citations